Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parkinson's Disease Psychosis”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Not applicableUnknownNCT04592965
What this trial is testing

Hallucinations in Parkinson's Disease

Who this might be right for
Parkinson Disease Psychosis
Olaf Blanke 40
Not applicableStudy completedNCT00024622
What this trial is testing

PET Scanning in Parkinson s Disease

Who this might be right for
SchizophreniaParkinson's Disease
National Institute of Mental Health (NIMH) 502
Post-approval studies (Phase 4)Looking for participantsNCT04373317
What this trial is testing

Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis

Who this might be right for
Parkinson's Disease Psychosis
VA Office of Research and Development 358
Post-approval studies (Phase 4)Looking for participantsNCT05590637
What this trial is testing

Comparing Antipsychotic Medications in LBD Over Time

Who this might be right for
Parkinson's Disease PsychosisDementia With Lewy Bodies
The University of Texas Health Science Center at San Antonio 94
Large-scale testing (Phase 3)Study completedNCT00477672
What this trial is testing

The Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis

Who this might be right for
Parkinson's Disease Psychosis
ACADIA Pharmaceuticals Inc. 298
Not applicableStudy completedNCT00360633
What this trial is testing

Psychiatric and Cognitive Manifestations of Parkinson's Disease

Who this might be right for
Parkinson's Disease
NYU Langone Health 36
Testing effectiveness (Phase 2)Study completedNCT02818777
What this trial is testing

Tolerability and Efficacy of Cannabidiol on Tremor in Parkinson's Disease

Who this might be right for
Parkinson's Disease
University of Colorado, Denver 13
Large-scale testing (Phase 3)Study completedNCT00658567
What this trial is testing

Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis

Who this might be right for
Parkinson's Disease Psychosis
ACADIA Pharmaceuticals Inc. 123
Testing effectiveness (Phase 2)Study completedNCT00009048
What this trial is testing

EMD 128130 for the Treatment of Parkinson's Disease

Who this might be right for
Parkinson's Disease
National Institute of Neurological Disorders and Stroke (NINDS) 30
Not applicableUnknownNCT04579887
What this trial is testing

Presence Hallucination in Parkinson's Disease

Who this might be right for
Parkinson Disease Psychosis
Olaf Blanke 10
Large-scale testing (Phase 3)Study completedNCT01174004
What this trial is testing

The Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis

Who this might be right for
Parkinson's Disease Psychosis
ACADIA Pharmaceuticals Inc. 199
Testing effectiveness (Phase 2)Study completedNCT00125138
What this trial is testing

Melperone (an Anti-Psychotic) in Patients With Psychosis Associated With Parkinson's Disease

Who this might be right for
Parkinson's DiseasePsychotic Disorders
Lundbeck LLC 90
Not applicableApproved For MarketingNCT02762591
What this trial is testing

Expanded Access of Pimavanserin for Patients With PD Psychosis

Who this might be right for
Parkinson's Disease Psychosis
ACADIA Pharmaceuticals Inc.
Not applicableStudy completedNCT02409823
What this trial is testing

Clinical Registry of Patients Under Treatment With Atypical Antipsychotics

Who this might be right for
SchizophreniaMajor Depressive DisorderBipolar Depressive Disorder+1 more
Pontifical Catholic University of Argentina 665
Very early researchUnknownNCT03661125
What this trial is testing

SRC Inhibition as a Potential Target for Parkinson's Disease Psychosis

Who this might be right for
Parkinson Disease Psychosis
King's College London 30
Testing effectiveness (Phase 2)Study completedNCT03582137
What this trial is testing

Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson's Disease

Who this might be right for
Parkinson Disease
University of Colorado, Denver 74
Testing effectiveness (Phase 2)Looking for participantsNCT05824728
What this trial is testing

Clinical Trial Evaluating the Efficacy and Safety of AGB101 for Treatment of Parkinson's Disease Related Psychosis

Who this might be right for
Parkinson Disease Psychosis
Johns Hopkins University 30
Testing effectiveness (Phase 2)Study completedNCT02969369
What this trial is testing

Evaluate the Efficacy, Safety and Tolerability of SEP-363856 in Subjects With Parkinson's Disease Psychosis

Who this might be right for
Parkinson Disease Psychosis
Otsuka Pharmaceutical Development & Commercialization, Inc. 39
Large-scale testing (Phase 3)Study completedNCT00550238
What this trial is testing

The Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis

Who this might be right for
Parkinson's Disease Psychosis
ACADIA Pharmaceuticals Inc. 459
Not applicableStudy completedNCT05240339
What this trial is testing

Characterization and Progression of Minor Phenomena in Parkinson's Disease (PD)

Who this might be right for
Parkinson DiseaseParkinson Disease PsychosisHallucinations+1 more
University of Rochester 38
Next Page